Patents Assigned to Nanogen
  • Patent number: 6838053
    Abstract: Electronically addressable microchips having covalently bound permeation layers and methods of making such covalently bonded permeation layers to microchips are provided. The covalent bonding is derived from combining the use of electrodes with silane derivatives. Such chemistry provides the ability to apply an electronic bias to the electrodes of the microchip while preventing permeation layer delaminating from the electrode surface.
    Type: Grant
    Filed: August 3, 2001
    Date of Patent: January 4, 2005
    Assignee: Nanogen, Inc.
    Inventors: Havens R. John, Theodore M. Winger, Jain Krotz, Smolko Dan, Thomas J. Onofrey
  • Publication number: 20040254098
    Abstract: The invention relates to a 3′-deoxypentopyranosylnucleic acid consisting essentially of 3′-deoxypentopyranosylnucleosides of the formulae (I) or of the formulae (II) 1
    Type: Application
    Filed: February 24, 2004
    Publication date: December 16, 2004
    Applicant: Nanogen Recognomics GmbH
    Inventors: Christian Miculka, Thomas Wagner, Norbert Windhab
  • Patent number: 6824740
    Abstract: Systems and methods for the electronic sample preparation of biological materials utilize the differential charge-to-mass ratio and/or the differential affinity of sample constituents to separation materials for sample preparation. An integrated system is provided for performing some or all of the processes of: receipt of biological materials, cell selection, sample purification, sample concentration, buffer exchange, complexity reduction and/or diagnosis and analysis. In one embodiment, one or more sample chambers adapted to receive a buffer solution are formed adjacent to a spacer region which may include a trap or other affinity material, electrophoretic motion of the materials to be prepared being effected through operation of electrodes. In another aspect of this invention, a transporter or dipstick serves to collect and permit transport of materials, such as nucleic acids, most preferably DNA and/or RNA.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: November 30, 2004
    Assignee: Nanogen, Inc.
    Inventors: Edward L. Sheldon, III, Thomas R. Jackson, Paul D. Swanson, Bradley S. Scott, Michael J. Heller
  • Patent number: 6821729
    Abstract: An electronic device for performing active biological operations includes an optically confining region including a support substrate having a via and a chip disposed in a facing arrangement with the support substrate, the chip including an array of electrodes disposed thereon. An optically accessible top member is disposed in a facing arrangement with the support substrate opposite the chip. The device further includes a source of illumination and an edge illumination layer having an input adapted to receive illumination from the source, and a terminal edge that outputs the illumination, the edge illumination layer being disposed adjacent to the support substrate. Illumination from the terminal edge of the illumination layer is directed into the optically confining region.
    Type: Grant
    Filed: September 12, 2001
    Date of Patent: November 23, 2004
    Assignee: Nanogen, Inc.
    Inventors: Donald E. Ackley, William F. Butler, Paul D. Swanson
  • Publication number: 20040209355
    Abstract: A platform for photoelectrophoretic transport and electronic hybridization of fluorescence labeled DNA oligonucleotides in a low conductivity electrolyte is described. A chemically stabilized semiconductor photodiode or photoconductor surface is coated with a streptavidin-agarose permeation layer. Micro-illumination of the surface generates photo-electrochemical currents that are used to electrophoretically transport and attach capture strands, preferably biotinylated DNA, to arbitrarily selected locations. The same process is then used to transport and electronically hybridize fluorescence labeled DNA target strands to the previously attached capture strands. Signal detection is accomplished either by a fluorescence scanner or a CCD camera. This represents a flexible electronic DNA assay platform that need not rely on pre-patterned microelectronic arrays.
    Type: Application
    Filed: February 4, 2004
    Publication date: October 21, 2004
    Applicant: Nanogen, Inc.
    Inventors: Carl Frederick Edman, Michael James Heller, Christian Gurtner, Rachel Formosa
  • Publication number: 20040210036
    Abstract: Peptide libraries containing peptides having the same net charge or same like charge are described, which may be used to screen for substrates of kinases and phosphatases and any other enzyme that causes a difference in net charge in a suitable substrate. The libraries are designed using representative amino acids for one or more classes of amino acids, thereby reducing the number of members in the peptide library. Reducing the number of peptides in the library to a manageable size permits the peptides to be segregated into individual wells of a microtiter plate, where the sequences of suitable substrates are immediately ascertainable upon exposure to enzyme by detecting the position of charge inverted peptide substrates in the plate.
    Type: Application
    Filed: April 15, 2003
    Publication date: October 21, 2004
    Applicant: NANOGEN, INC.
    Inventors: Brian Dwyer, John Heimbold, Siobhan Miick
  • Publication number: 20040198966
    Abstract: The invention relates to a pentopyranosylnucleoside of the formula (I) or of the formula (II) 1
    Type: Application
    Filed: August 19, 2003
    Publication date: October 7, 2004
    Applicant: Nanogen Recognomics GmbH
    Inventors: Christian Miculka, Norbert Windhab, Tilmann Brandstetter, Gerhard Burdinski
  • Patent number: 6780584
    Abstract: This invention pertains to the design, fabrication, and uses of an electronic system which can actively carry out and control multi-step and multiplex reactions in macroscopic or microscopic formats. In particular, these reactions include molecular biological reactions, such as nucleic acid hybridizations, nucleic acid amplification, sample preparation, antibody/antigen reactions, clinical diagnostics, combinatorial chemistry and selection, drug screening, oligonucleotide and nucleic acid synthesis, peptide synthesis, biopolymer synthesis and catalytic reactions. A key feature of the present invention is the ability to control the localized concentration of two or more reaction-dependant molecules and their reaction environment in order to greatly enhance the rate and specificity of the molecular biological reaction.
    Type: Grant
    Filed: September 27, 2000
    Date of Patent: August 24, 2004
    Assignee: Nanogen, Inc.
    Inventors: Carl F. Edman, Eugene Tu, Christian Gurtner, Lorelei Westin, Michael J. Heller
  • Publication number: 20040149582
    Abstract: An addressable biologic electrode array includes an array of electrodes disposed on a support, the array of electrodes being selectively addressed and driven using a memory associated with each electrode of the array, the driven electrodes being driven at one of a plurality of stimulus levels by a source of electrical current or voltage external to the array.
    Type: Application
    Filed: January 23, 2004
    Publication date: August 5, 2004
    Applicant: Nanogen, Inc.
    Inventor: Gregory T. A. Kovacs
  • Publication number: 20040146880
    Abstract: An assay system and methods are described where patient samples containing genomic DNA are analyzed for the presence of known genetic polymorphisms using a universal reporter strategy. In a preferred embodiment, the amplified DNA is localized at test sites in an array of sites on a microchip followed by a series of hybridization reactions that screen for the presence of a single mutation from among a number of mutations, and allow the identification of specific mutations. In addition to universal reporters, the assay may use blockers and discriminators for screening and identification of known polymorphisms.
    Type: Application
    Filed: July 24, 2003
    Publication date: July 29, 2004
    Applicant: Nanogen, Inc.
    Inventors: Ray R. Radtkey, Lance C. Held, Robert B. Wallace, Karen Menge, David Canter
  • Publication number: 20040142451
    Abstract: The invention relates to conjugates including at least one linker, a biomolecule coupled to the linker, and cyclohexane derivatives of the following formula: 1
    Type: Application
    Filed: December 23, 2003
    Publication date: July 22, 2004
    Applicant: Nanogen Recognomics GmbH
    Inventors: Christian Miculka, Norbert Windhab, Albert Eschenmoser, Stefan Scherer, Gerhard Quinkert
  • Patent number: 6753148
    Abstract: Methods and apparatus are provided for the analysis and determination of the nature of repeat units in a genetic target. In one method of this invention, the nature of the repeat units in the genetic target is determined by the steps of providing a plurality of hybridization complex assays arrayed on a plurality of test sites, where the hybridization complex assay includes at least a nucleic acid target containing a simple repetitive DNA sequence, a capture probe having a first unique flanking sequence and n repeat units, where n=0,1,2 . . . , or fractions thereof, being complementary to the target sequence, and a reporter probe having a selected sequence complementary to the same target sequence strand wherein the selected sequence of the reporter includes a second unique flanking sequence and m repeat units, where m=0,1,2 . . . , or fractions thereof, but where the sum of repeat units in the capture probe plus reporter probe is greater than 0 (n+m>0).
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: June 22, 2004
    Assignee: Nanogen, Inc.
    Inventors: Ronald G. Sosnowski, Eugene Tu
  • Publication number: 20040086917
    Abstract: Methods for electronic perturbation of fluorescence, chemilluminescence and other emissive materials provide for molecular biological analysis.
    Type: Application
    Filed: July 18, 2003
    Publication date: May 6, 2004
    Applicant: Nanogen, Inc.
    Inventors: Michael J. Heller, Eugene Tu, Ronald G. Sosnowski, James P. O'Connell
  • Patent number: 6726880
    Abstract: An electronic device for performing biological operations includes a support substrate and an array of microlocations disposed on the substrate. The array of microlocations include electronically addressable electrodes. A first collection electrode is disposed on the substrate and adjacent to a first side of the array of microlocations. A second collection electrode is disposed on the substrate and adjacent to a second side of the array of microlocations, the second side of the array being opposite of the first side such that the array of microlocations is disposed between the first and second collection electrodes. A flow cell is supported on the substrate. Preferably, the combined area of the collection electrodes is a substantial fraction, preferably at least 50% of the area of the footprint of the flow cell.
    Type: Grant
    Filed: June 19, 2000
    Date of Patent: April 27, 2004
    Assignee: Nanogen, Inc.
    Inventors: Donald E. Ackley, Paul D. Swanson, Scott O. Graham, Elizabeth L. Mather, Timothy L. LeClair, William F. Butler
  • Publication number: 20040077074
    Abstract: A device includes an inlet for receipt of a sample. A first chamber is coupled to the inlet and includes at least one affinity region. A second chamber is disposed adjacent to the first chamber. The first chamber and the second chamber share a common intermediate member, the intermediate member having at least one via formed in the common intermediate member. The second chamber includes an assay chip comprising an array of addressable electrodes. An outlet is coupled to the second chamber. The device may be used to selectively amplify and elute nucleic acids for subsequent detection and analysis.
    Type: Application
    Filed: October 14, 2003
    Publication date: April 22, 2004
    Applicant: Nanogen, Inc.
    Inventors: Donald E. Ackley, Edward L. Sheldon, Michael K. Krihak
  • Patent number: 6706473
    Abstract: A platform for photoelectrophoretic transport and electronic hybridization of fluorescence labeled DNA oligonucleotides in a low conductivity electrolyte is described. A chemically stabilized semiconductor photodiode or photoconductor surface is coated with a streptavidin-agarose permeation layer. Micro-illumination of the surface generates photo-electrochemical currents that are used to electrophoretically transport and attach capture strands, preferably biotinylated DNA, to arbitrarily selected locations. The same process is then used to transport and electronically hybridize fluorescence labeled DNA target strands to the previously attached capture strands. Signal detection is accomplished either by a fluorescence scanner or a CCD camera. This represents a flexible electronic DNA assay platform that need not rely on pre-patterned microelectronic arrays.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: March 16, 2004
    Assignee: Nanogen, Inc.
    Inventors: Carl Frederick Edman, Michael James Heller, Christian Gurtner, Rachel Formosa
  • Patent number: 6699978
    Abstract: The present invention relates to a linker nucleoside, its preparation and use for the covalent bonding of biomolecules to oligonucleotides, in particular p-RNA oligonucleotides.
    Type: Grant
    Filed: July 11, 2000
    Date of Patent: March 2, 2004
    Assignee: Nanogen Recognomics GmbH
    Inventors: Christian Miculka, Norbert Windhab, Tilmann Brandstetter, Stefan Scherer
  • Publication number: 20040038420
    Abstract: The present invention is directed to devices and methods for carrying out and/or monitoring biological reactions in response to electrical stimuli. A programmable multiplexed active biologic array includes an array of electrodes coupled to sample-and-hold circuits. The programmable multiplexed active biologic array includes a digital interface that allows external control of the array using an external processor. The circuit may monitor, digitally control, and deliver electrical stimuli to the electrodes individually or in selected groups.
    Type: Application
    Filed: August 20, 2002
    Publication date: February 26, 2004
    Applicant: NANOGEN, INC.
    Inventors: Richard Gelbart, Don L. Powrie, Paul David Swanson
  • Patent number: 6696555
    Abstract: The invention relates to a 3′-deoxypentopyranosylnucleic acid consisting essentially of 3′-deoxypentopyranosylnucleosides of the formulae (I) or of the formulae (II) their preparation and use for the production of a therapeutic, diagnostic and/or electronic component.
    Type: Grant
    Filed: April 19, 2001
    Date of Patent: February 24, 2004
    Assignee: Nanogen Recognomics GmbH
    Inventors: Christian Miculka, Thomas Wagner, Norbert Windhab
  • Patent number: 6689884
    Abstract: The invention relates to a compound of formula (I), wherein R1 is NR3R4, OR3 or SR3 with R3 and R4 being H or CnH2n+1 independently of each other and being the same or different, n being a whole number from 1 to 12; R2 is equal to CmH2m—C(X)—Y with X being ═O, ═S or ═N, Y being equal to OR3, NR3R4 or SR3, R3 and R4 having the same meaning given above, and m being a whole number from 1 to 4; or R2 is equal to CmH2m—Z—Y′ with Z being a sulfonyl, phosphonyl, ether or amine group, Y′ being equal to H, CnH2n+1, OR3, NR3R4 or SR3 then Z is sulphonyl or phosphonyl group, n, R3 and R4 having the meaning given above, and Y′ being equal to CnH2n+1 when Z is an ether or an amine group; A, B, and D are the same or different and mean CR5R6, O, NR7 ou S independently of each other with R5, R6 and R7 being H or CnH2n+1, independently of each other, n having the meaning given above; and C is equal to CR8 or N with R8 having the meaning of R5 indepen
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: February 10, 2004
    Assignee: Nanogen Recognomics GmbH
    Inventors: Christian Miculka, Norbert Windhab, Albert Eschenmoser, Stefan Scherer, Gerhard Quinkert